CELLDEX THERAPEUTICS INC NEW - COM (CLDX)

CUSIP: 15117B103

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / COM
Total 13F shares
81,799,533
Share change
+7,009,482
Total reported value
$295,277,280
Put/Call ratio
186%
Price per share
$3.61
Number of holders
133
Value change
+$25,361,577
Number of buys
60
Number of sells
60

Quarterly Holders Quick Answers

What is CUSIP 15117B103?
CUSIP 15117B103 identifies CLDX - CELLDEX THERAPEUTICS INC NEW - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CELLDEX THERAPEUTICS INC NEW - COM (CLDX) as of Q1 2017

As of 31 Mar 2017, CELLDEX THERAPEUTICS INC NEW - COM (CLDX) was held by 133 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 81,799,533 shares. The largest 10 holders included FMR LLC, VANGUARD GROUP INC, BlackRock Inc., KLP Enterprises, LLC, COLUMBIA WANGER ASSET MANAGEMENT LLC, FRANKLIN RESOURCES INC, STATE STREET CORP, Meditor Group Ltd, DEUTSCHE BANK AG\, and NORTHERN TRUST CORP. This page lists 133 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.